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The genetic background of hypoplastic left heart syndrome (HLHS) is still
unknown. Cardiac differentiation from pluripotent stem cells (PSCs) can recapitu-
late the cardiogenesis in vitro, and PSC technology could be useful to dissect the
diseases with the complex mechanisms. In the past few years, some researches were
reported to seek the pathogenesis of HLHS by using PSCs. This paper reports the
achievements.
1. Gaber N et al. showed that human embryonic stem cells (hESCs) during cardio-
vascular lineage with hypoxia recapitulated the phenotype of the HLHS heart,
which was characterized by increased expression of the oncogenes and TGF-ß1,
damaged DNA, and senescence with cell cycle arrest [1]. The phenotypes were
rescued by TGF-ß1 inhibition.
2. Jiang Y et al. generated disease-specific induced pluripotent stem cells (iPSCs)
from a patient with HLHS [2]. HLHS-iPS-derived cardiomyocytes demonstrated
repression of MESP1, TNNT2, and delayed expression of GATA4 compared
with hESCs and control-iPSCs. HLHS-iPS-derived cardiomyocyte showed cal-
cium oscillation under caffeine and inositol trisphosphate receptor upregulation,
presumably as a result of ryanodine receptor dysfunction.
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3. Kobayashi J et al. generated five HLHS-iPSC lines and found repression of the
transcripts such as NKX2-5, HAND1, HAND2, NOTCH1, HEY1, HEY2, and
TBX2 in HLHS-iPS-derived cardiomyocytes [3]. The promoter activities of
SRE, TNNT2, and NPPA were suppressed in HLHS-derived cardiac progenitor
cells and iPSCs compared with those from bi-ventricle (BV). All promoter
activities of both cell types could be fully restored by co-transfection of
NKX2-5, HAND1, and NOTCH1, and co-transfection of the shRNAs into
BV-derived cells reduced the promoter activation. HLHS-derived
cardiomyocytes demonstrated repressed H3K4me2 and acH3 and increased
H3K27me3 in NKX2-5 promoter, implying suppressed NKX2-5 promoter
activity.
Taken together, the PSC technology can be useful to dissect the complex heart
diseases. Further investigation using this technique is necessary to determine the
pathogenesis of HLHS (Fig. 47.1).
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Fig. 47.1 PSC technology models HLHS. Three possible mechanisms of HLHS were unveiled by
PSCs. Bar, 200 μm
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